Table 4.
Acute and late toxicities in patients treated with HDR interstitial brachytherapy
| Grade 1 |
Grade 2 |
Grade 3 |
Grade 4 |
|||||
|---|---|---|---|---|---|---|---|---|
| Toxicity | n | % | n | % | n | % | n | % |
| Acute toxicity | ||||||||
| Genitourinary | 48 | 41 | 3 | 2.6 | 0 | 0 | 0 | 0 |
| Gastrointestinal | 40 | 34 | 9 | 7.8 | 1 | 0.9 | 0 | 0 |
| Late toxicity | ||||||||
| Genitourinary | 7 | 6 | 4 | 3.4 | 5 | 4.3 | 0 | 0 |
| Gastrointestinal | 8 | 6.9 | 9 | 7.8 | 9 | 7.8 | 0 | 0 |
| Vaginal | 0 | 0 | 1 | 0.9 | 1 | 0.9 | 0 | 0 |
| Fistula formation | ||||||||
| Vesicovaginal | 0 | 0 | 2 | 1.7 | 2 | 1.7 | 0 | 0 |
| Rectovaginal | 0 | 0 | 0 | 0 | 1 | 0.9 | 1 | 0.9 |
Abbreviation: HDR = high-dose-rate.